The etiopathogenesis of autoimmunity

Seminars in Liver Disease

Volumn 25, Issue 3, 2005, Pages 239-250

  Mackay, Ian R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Autoimmunity; Gene environment interaction; Immune response; Immune tolerance; Somatic mutation

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN;

AIRE GENE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BONE MARROW CELL; ENVIRONMENTAL FACTOR; EVOLUTION; GENE DELETION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LATENT PERIOD; LYMPHOCYTE; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; SOMATIC MUTATION; THYMOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; ENVIRONMENT; EVOLUTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNE TOLERANCE; MAMMALS; TIME FACTORS;

EID: 24344505815     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916330     Document Type: Review

References (71)

1. Klein J, Nikolaidis N. The descent of the antibody-based immune system by gradual evolution. Proc Natl Acad Sci USA 2005;102:169-174
2. Mackay IR. The "Autoimmune diseases" 40th anniversary. Autoimmun Rev 2002;1:5-11
3. Mackay IR. Roots and routes to autoimmunity. In: Immunology-The Making of a Modern Science London: Academic Press; 1995:49-62
4. Burnet FM. The immunological significance of the thymus. An extension of the clonal theory of immunity. Aust Ann Med 1962;11:79-91
5. Bielschowsky M, Helyer BJ, Howie JB. Spontaneous haemolytic anaemia in mice of the NZB/BL strain. Proc Univ Otago Med Sch 1959;37:9-11
6. Makino S, Kunimoto K, Muraoka Y, et al. Breeding of a nonobese, diabetic strain of mice. Exp Anim 1980;29: 1-13
7. Rose NR, Mackay IR. Prelude. In: Rose NR, Mackay IR, eds. The Autoimmune Diseases, 3rd ed. San Diego, CA: Academic Press; 1998:1-4
8. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005;352:1685-1695
9. MacDonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005;307:1920-1925
10. Sollid M. Molecular basis of celiac disease. Annu Rev Immunol 2000;18:53-81
11. Mackay IR. Hepatic disease and systemic lupus erythematosus. Coincidence or convergence. In: Lahita RG ed. Systemic Lupus Erythematosus, 4th ed. San Diego, CA: Elsevier Science; 2004:993-1017
12. Kinoshita H, Omagari K, Whittingham S, et al. Autoimmune cholangitis and primary biliary cirrhosis-an autoimmune enigma. Liver 1999;19:122-128
13. Alsen PS, Davis KL. Inflammatory response in Alzheimer's disease: implications for therapy. Am J Psychiatry 1994;151: 1105-1113
14. Lazaridis KN, La Russo NF. Examining the increased IgM production and ursodeoxycholic acid treatment in PBC. Gastroenterology 2005;128:498-500
15. Tolstoy L. Anna Karenina. Translated by Townsend RS. Geneva: Edito-Service S.A.; 1887
16. Casciola-Rosen L, Andrade F, Ulanet D, et al. Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity. J Exp Med 1999;190:815-825
17. Höglund P, Mintern J, Waltzinger C, et al. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell autoantigens in the pancreatic lymph nodes. J Exp Med 1999;189:331-339
18. Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of a natural tissue autoantibody exclusively by dendritic cells in the draining lymph node. J Exp Med 2002;196:1079-1090
19. Vinuesa CG, Tangye SG, Moser B, Mackay CR. T fofficular helper cells, and their role in T dependent antibody responses and autoimmunity. Nat Rev Immunol 2005. In press
20. Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999;341: 1520-1529
21. Mackay CR. Immunological memory. Adv Immunol 1993; 53:217-265
22. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996;272: 54-60
23. Zinkernagel RM. On differences between immunity and immunological memory. Curr Opin Immunol 2002;14:523-536
24. Seder RA, Ahmed R. Similarities and differences in CD44+ and CD8+ effector and memory T cell generation. Nat Immunol 2003;4:835-842
25. Holmes S, He M, Xu T, Lee PL. Memory T cells have gene expression patterns intermediate between naïve and effector. Proc Natl Acad Sci USA 2005;102:5519-5523
26. Mackay IR, Burnet FM. Autoimmune diseases. In: Kugelmass 'IN, ed. Springfield; 1963
27. Serreze DV, Fleming SA, Chapman HD, et al. B lymphocytes are critical antigen presenting cells for the initiation of T-cell mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998;161:3912-3918
28. Monach PA, Benoist C, Mathis D. The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv Immunol 2004;82:217-248
29. Amiramahdi SF, Whittingham S, Crombie DE, et al. Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells. Arthritis Rheum 2005;52:1897-1906
30. Ruiz-Arguelles A, Rivadeneyra-Espinoza L, Alarcon-Segovia D. Antibody penetration into living cells: pathogenic, preventive and immunotherapeutic implications. Curr Pharm Des 2003;9:1881-1887
31. Cope AP, Feldmann M. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease. Curr Opin Immunol 2004;16:780-786
32. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747-755
33. Goldstein G, Mackay IR. The Human Thymus. London: William Heineman; 1969
34. Whittingham S, Mackay IR. The 'pemphigus' antibody and immunopathies affecting the thymus. Br J Dermatol 1971;84: 1-6
35. Cohen IR. The cognitive paradigm and the immunological homunculus. Immunol Today 1992;13:490-494
36. Anderson MS, Venanzi ES, Klein L, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002;298:1395-1401
37. Kuroda N, Mitani T, Takeda N, et al. Development of autoimmunity against unrepressed target antigen in the thymus of aire-deficient mice. J Immunol 2005;174:1862-1870
38. Grimalde CM, Hicks R, Diamond B. B cell selection and susceptibility to autoimmunity. J Immunol 2005;174:1775-1781
39. Verkoczy LK, Martensson AS, Nemazee D. The scope of receptor editing and its association with autoimmunity. Curr Opin Immunol 2004;16:808-814
40. Rice JS, Newman J, Wang C, et al. Receptor editing in peripheral B cell tolerance. Proc Natl Acad Sci USA 2005; 102:1608-1613
41. Ohashi PS, Oehen S, Buerki K, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991;65:305-317
42. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2002;2:465-475
43. Hori S, Takahashi T, Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol 2003;81:331-371
44. Jiang H, Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 2004;114:1198-1208
45. Roberts WK, Darnell RB. Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol 2004;16:616-622
46. Mackay IR. Science, medicine and the future. Tolerance and autoimmunity. BMJ 2000;321:93-96
47. Invernizzi P, Seltni C, Mackay IR, et al. From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2005;3:401-410
48. Gillespie KM, Bain SC, Barnett AH, et al. The rising incidence of type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 2005;364:1699-1700
49. Pugliese A, Gianani R, Moromisato R, et al. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes 1995;44:608-613
50. Outschoorn IM, Rose NR, Burek CL, et al. Heritability of levels of autoantibodies using the method of plotting regression of offspring on midparent (ROMP). Autoimmunity 2005;34:325-326
51. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-1533
52. Tuomilehto J, Zimmet P, Mackay IR, et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 1994;343:1383-1385
53. Metcalf JV, Bhopal RS, Gray J, et al. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol 1997;26:830-836
54. Trudeau JD, Dutz JP, Arany E, et al. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes 2000; 49:1-7
55. Selmi C, Balkwill DL, Invernizzi P, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003;38:1250-1257
56. Wekerle H, Hohlfeld R. Molecular memory in multiple sclerosis. N Engl J Med 2003;349:185-186
57. Davies JM. Multiauthor review: molecular mimicry. Cell Mol Life Sci 2000;57:523-578
58. Nitz N, Gomes C, de Cassia Rosa A, et al. Heritable integration of kDNA minicircle sequences from Trypanosoma cruzi into the avian genome: insights into human Chagas disease. Cell 2004;118:175-186
59. Long SA, Quan C, Van de Water J, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001;167:2956-2963
60. Coggon DIW, Martyn CN. Time and chance: the stochastic nature of disease causation. Lancet 2005;365:1434-1437
61. Puck JM. Somatic mutations-not just for cancer anymore. N Engl J Med 2004;351:1388-1390
62. Burch PJR. An enquiry concerning growth, disease and aging. Edinburgh, United Kingdom: Oliver and Boyd; 1968
63. Burnet FM. Autoimmunity and Autoimmune Disease, Chapter 10. Lancaster, United Kingdom: Medical and Technical Publishing; 1972
64. Fischer A, Rieux-Laucat F, Le Deist F. Autoimmune lymphoproliferative syndromes (ALPS): models for the study of peripheral tolerance. Rev Immunogenet 2000;2:52-60
65. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-562
66. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004;22:431-456
67. Gough SCL, Walker LSK, Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunol Rev 2005;204: 102-115
68. Anderton SM. Post-translational modifications of self antigens-implications for autoimmunity. Curr Opin Immunol 2004;16:753-758
69. Amano K, Leung PSC, Rieger R, et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005; 174:5874-5883
70. Sercarz EE, Lehmann PV, Ametani A, Benichou G. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993;11:729-766
71. Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999;6: 6-12